-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

KLF2 and Hypercoagulability in Myeloproliferative Neoplasms

Scientific Workshop on the Interplay between Coagulation and Malignancy
Program: Scientific Workshops
Session: Coagulation Alterations in Hematologic Malignancies
Friday, December 8, 2023, 2:05 PM-3:00 PM

Josef T. Prchal, MD

Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Disclosures: Prchal: PharmaEssentia: Research Funding.